To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

ISASS: XLIF and TLIF for treatment of low-grade spondylolisthesis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2013

ISASS: XLIF and TLIF for treatment of low-grade spondylolisthesis

Vol: 2| Issue: 3| Number:109| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

XLIF vs. MAS TLIF for the Treatment of Degenerative Spondylolisthesis: Perioperative Clinical Outcomes from a Prospective Multi-Center Randomized Study

Contributing Authors:
R Isaacs J Sembrano F Zahrawi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

34 patients were randomized to compare the clinical and radiographic outcomes of two different procedures for the treatment of low-grade spondylolisthesis. Patients received either lateral lumbar interbody fusion (XLIF) or transforaminal lumbar interbody fusion (TLIF) and were assessed after 3 months. Results indicated that a higher incidence of perioperative hip flexion weakness was observed in t...

Join the Conversation

Please Login or Join to leave comments.